Halozyme Therapeutics, Inc.
IT ˙ BIT ˙ US40637H1095
58,52 € 0,00 (0,00%)
2026-06-03
DEL PRIS
SecurityIT:1HALO / Halozyme Therapeutics, Inc.
InstitutionCitigroup Inc
Latest Disclosed Ownership120,341 shares
Latest Disclosed Value $ 7,777,639
Citigroup Inc ownership in 1HALO / Halozyme Therapeutics, Inc.

On May 11, 2026 - Citigroup Inc filed a 13F-HR form disclosing ownership of 120,341 shares of Halozyme Therapeutics, Inc. (IT:1HALO) valued at $6,496,007 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 13, 2026 disclosing 504,103 shares of Halozyme Therapeutics, Inc.. This represents a change in shares of -76.13% during the quarter. The current value of the position is $7,042,355 USD.

Citigroup Inc has a history of taking positions in derivatives of the underlying security (1HALO) in the form of stock options. The firm currently holds call options representing 23,700 of underlying shares valued at $1,531,731 USD and put options representing 23,700 of underlying shares valued at $1,531,731 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

IT:1HALO / Halozyme Therapeutics, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-11 2026-03-31 13F HALOZYME THERAPEUTICS COM 40637H109 120,341 -383,762 -76.13 7,778 -77.08 0.0017
2026-02-13 2025-12-31 13F HALOZYME THERAPEUTICS COM 40637H109 504,103 -45,788 -8.33 33,926 -15.88 0.0150
2025-11-10 2025-09-30 13F HALOZYME THERAPEUTICS COM 40637H109 549,891 172,384 45.66 40,329 105.37 0.0180
2025-08-11 2025-06-30 13F HALOZYME THERAPEUTICS COM 40637H109 377,507 -205,370 -35.23 19,638 -47.20 0.0096
2025-05-12 2025-03-31 13F HALOZYME THERAPEUTICS COM 40637H109 582,877 266,914 84.48 37,193 146.21 0.0190
2025-02-12 2024-12-31 13F HALOZYME THERAPEUTICS COM 40637H109 315,963 203,246 180.32 15,106 134.17 0.0090
2024-11-12 2024-09-30 13F HALOZYME THERAPEUTICS COM 40637H109 112,717 44,401 64.99 6,452 80.35 0.0037
2024-08-12 2024-06-30 13F HALOZYME THERAPEUTICS COM 40637H109 68,316 -151,304 -68.89 3,577 -59.96 0.0023
2024-05-10 2024-03-31 13F HALOZYME THERAPEUTICS COM 40637H109 219,620 69,729 46.52 8,934 61.29 0.0059
2024-02-09 2023-12-31 13F HALOZYME THERAPEUTICS COM 40637H109 149,891 43,966 41.51 5,540 36.90 0.0039
2023-12-06 2023-09-30 13F/A-1 HALOZYME THERAPEUTICS COM 40637H109 105,925 -22,522 -17.53 4,046 -12.67 0.0030
2023-11-09 2023-09-30 13F HALOZYME THERAPEUTICS COM 40637H109 105,925 -22,522 4,046 0.0012
2023-08-10 2023-06-30 13F HALOZYME THERAPEUTICS COM 40637H109 128,447 -43,659 -25.37 4,633 -29.50 0.0030
2023-05-11 2023-03-31 13F HALOZYME THERAPEUTICS COM 40637H109 172,106 87,867 104.31 6,573 37.12 0.0046
2023-02-09 2022-12-31 13F HALOZYME THERAPEUTICS COM 40637H109 84,239 -131,470 -60.95 4,793 -43.80 0.0038
2022-11-10 2022-09-30 13F HALOZYME THERAPEUTICS COM 40637H109 215,709 109,825 103.72 8,528 83.04 0.0061
2022-08-10 2022-06-30 13F HALOZYME THERAPEUTICS COM 40637H109 105,884 65,432 161.75 4,659 188.66 0.0035
2022-05-12 2022-03-31 13F HALOZYME THERAPEUTICS COM 40637H109 40,452 -127,346 -75.89 1,614 -76.08 0.0010
2022-02-10 2021-12-31 13F HALOZYME THERAPEUTICS COM 40637H109 167,798 64,073 61.77 6,747 59.88 0.0036
2021-11-10 2021-09-30 13F HALOZYME THERAPEUTICS COM 40637H109 103,725 -18,239 -14.95 4,220 -23.80 0.0025
2021-08-10 2021-06-30 13F HALOZYME THERAPEUTICS COM 40637H109 121,964 -91,747 -42.93 5,538 -37.85 0.0033
2021-05-13 2021-03-31 13F HALOZYME THERAPEUTICS COM 40637H109 213,711 167,449 361.96 8,910 350.91 0.0058
2021-02-11 2020-12-31 13F HALOZYME THERAPEUTICS COM 40637H109 46,262 27,926 152.30 1,976 309.96 0.0012
2020-11-12 2020-09-30 13F HALOZYME THERAPEUTICS COM 40637H109 18,336 -99,552 -84.45 482 -84.75 0.0003
2020-08-12 2020-06-30 13F HALOZYME THERAPEUTICS COM 40637H109 117,888 23,736 25.21 3,160 86.54 0.0025
2020-05-12 2020-03-31 13F HALOZYME THERAPEUTICS COM 40637H109 94,152 51,240 119.41 1,694 122.89 0.0015
2020-02-12 2019-12-31 13F HALOZYME THERAPEUTICS COM 40637H109 42,912 -10,022 -18.93 760 -7.43 0.0006
2019-11-08 2019-09-30 13F HALOZYME THERAPEUTICS COM 40637H109 52,934 10,149 23.72 821 11.70 0.0007
2019-08-12 2019-06-30 13F HALOZYME THERAPEUTICS COM 40637H109 42,785 30 0.07 735 6.68 0.0006
2019-05-13 2019-03-31 13F HALOZYME THERAPEUTICS COM 40637H109 42,755 -206,089 -82.82 689 -81.08 0.0007
2019-02-12 2018-12-31 13F HALOZYME THERAPEUTICS COM 40637H109 248,844 210,520 549.32 3,641 423.13 0.0037
2018-11-13 2018-09-30 13F HALOZYME THERAPEUTICS COM 40637H109 38,324 9,159 31.40 696 41.46 0.0006
2018-08-10 2018-06-30 13F HALOZYME THERAPEUTICS COM 40637H109 29,165 -121,085 -80.59 492 -83.28 0.0005
2018-05-11 2018-03-31 13F HALOZYME THERAPEUTICS COM 40637H109 150,250 -32,735 -17.89 2,943 -20.61 0.0024
2018-02-12 2017-12-31 13F HALOZYME THERAPEUTICS COM 40637H109 182,985 115,843 172.53 3,707 217.92 0.0030
2017-11-13 2017-09-30 13F HALOZYME THERAPEUTICS COM 40637H109 67,142 -22,548 -25.14 1,166 1.39 0.0010
2017-08-11 2017-06-30 13F HALOZYME THERAPEUTICS COM 40637H109 89,690 18,970 26.82 1,150 25.41 0.0010
2017-05-12 2017-03-31 13F HALOZYME THERAPEUTICS COM 40637H109 70,720 -280,348 -79.86 917 -73.56 0.0008
2017-02-10 2016-12-31 13F HALOZYME THERAPEUTICS COM 40637H109 351,068 307,260 701.38 3,468 554.34 0.0031
2016-11-10 2016-09-30 13F HALOZYME THERAPEUTICS COM 40637H109 43,808 26,716 156.31 530 258.11 0.0005
2016-08-12 2016-06-30 13F HALOZYME THERAPEUTICS COM 40637H109 17,092 -73,963 -81.23 148 -82.83 0.0002
2016-05-13 2016-03-31 13F HALOZYME THERAPEUTICS COM 40637H109 91,055 64,795 246.74 862 89.45 0.0010
2016-02-12 2015-12-31 13F HALOZYME THERAPEUTICS COM 40637H109 26,260 -61,184 -69.97 455 -61.24 0.0005
2015-11-13 2015-09-30 13F HALOZYME THERAPEUTICS COM 40637H109 87,444 37,802 76.15 1,174 4.73 0.0011
2015-08-13 2015-06-30 13F HALOZYME THERAPEUTICS COM 40637H109 49,642 19,314 63.68 1,121 158.89 0.0010
2015-05-14 2015-03-31 13F HALOZYME THERAPEUTICS COM 40637H109 30,328 -19,271 -38.85 433 -9.41 0.0004
2015-02-17 2014-12-31 13F HALOZYME THERAPEUTICS COM 40637H109 49,599 9,505 23.71 478 30.96 0.0004
2014-11-14 2014-09-30 13F HALOZYME THERAPEUTICS COM 40637H109 40,094 18,760 87.93 365 73.81 0.0003
2014-08-14 2014-06-30 13F HALOZYME THERAPEUTICS COM 40637H109 21,334 -38,102 -64.11 210 -72.19 0.0002
2014-05-15 2014-03-31 13F HALOZYME THERAPEUTICS COM 40637H109 59,436 20,874 54.13 755 30.62 0.0008
2014-02-14 2013-12-31 13F HALOZYME THERAPEUTICS COM 40637H109 38,562 14,443 59.88 578 117.29 0.0005
2013-11-14 2013-09-30 13F HALOZYME THERAPEUTICS COM 40637H109 24,119 23,228 2,606.96 266 3,225.00 0.0002
2013-08-14 2013-06-30 13F HALOZYME THERAPEUTICS COM 40637H109 891 891 8 0.0000
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-11 2026-03-31 13F HALOZYME THERAPEUTICS COM Call 23,700 1,532 n/a n/a n/a
2025-05-12 2025-03-31 13F HALOZYME THERAPEUTICS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2025-02-12 2024-12-31 13F HALOZYME THERAPEUTICS COM Call 24,000 1,147 n/a n/a n/a
2021-05-13 2021-03-31 13F HALOZYME THERAPEUTICS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2021-02-11 2020-12-31 13F HALOZYME THERAPEUTICS COM Call 1,800 -82.18 77 -70.94 n/a n/a n/a
2020-11-12 2020-09-30 13F HALOZYME THERAPEUTICS COM Call 10,100 -72.55 265 -73.15 n/a n/a n/a
2020-08-12 2020-06-30 13F HALOZYME THERAPEUTICS COM Call 36,800 -12.80 987 30.04 n/a n/a n/a
2020-05-12 2020-03-31 13F HALOZYME THERAPEUTICS COM Call 42,200 -31.05 759 -30.05 n/a n/a n/a
2020-02-12 2019-12-31 13F HALOZYME THERAPEUTICS COM Call 61,200 8.90 1,085 24.43 n/a n/a n/a
2019-11-08 2019-09-30 13F HALOZYME THERAPEUTICS COM Call 56,200 -12.73 872 -21.16 n/a n/a n/a
2019-08-12 2019-06-30 13F HALOZYME THERAPEUTICS COM Call 64,400 133.33 1,106 149.10 n/a n/a n/a
2019-05-13 2019-03-31 13F HALOZYME THERAPEUTICS COM Call 27,600 30.19 444 43.23 n/a n/a n/a
2019-02-12 2018-12-31 13F HALOZYME THERAPEUTICS COM Call 21,200 -7.83 310 -25.84 n/a n/a n/a
2018-11-13 2018-09-30 13F HALOZYME THERAPEUTICS COM Call 23,000 206.67 418 229.13 n/a n/a n/a
2018-08-10 2018-06-30 13F HALOZYME THERAPEUTICS COM Call 7,500 -61.34 127 -66.58 n/a n/a n/a
2018-05-11 2018-03-31 13F HALOZYME THERAPEUTICS COM Call 19,400 -42.43 380 -44.36 n/a n/a n/a
2018-02-12 2017-12-31 13F HALOZYME THERAPEUTICS COM Call 33,700 -48.39 683 -39.77 n/a n/a n/a
2017-11-13 2017-09-30 13F HALOZYME THERAPEUTICS COM Call 65,300 310.69 1,134 455.88 n/a n/a n/a
2017-08-11 2017-06-30 13F HALOZYME THERAPEUTICS COM Call 15,900 -29.96 204 -30.61 n/a n/a n/a
2017-05-12 2017-03-31 13F HALOZYME THERAPEUTICS COM Call 22,700 -4.22 294 25.64 n/a n/a n/a
2017-02-10 2016-12-31 13F HALOZYME THERAPEUTICS COM Call 23,700 -23.05 234 -37.10 n/a n/a n/a
2016-11-10 2016-09-30 13F HALOZYME THERAPEUTICS COM Call 30,800 -31.40 372 -3.88 n/a n/a n/a
2016-08-12 2016-06-30 13F HALOZYME THERAPEUTICS COM Call 44,900 9.51 387 -0.26 n/a n/a n/a
2016-05-13 2016-03-31 13F HALOZYME THERAPEUTICS COM Call 41,000 -1.20 388 -46.04 n/a n/a n/a
2016-02-12 2015-12-31 13F HALOZYME THERAPEUTICS COM Call 41,500 59.00 719 104.84 n/a n/a n/a
2015-11-13 2015-09-30 13F HALOZYME THERAPEUTICS COM Call 26,100 3.57 351 -38.31 n/a n/a n/a
2015-08-13 2015-06-30 13F HALOZYME THERAPEUTICS COM Call 25,200 569 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-11 2026-03-31 13F HALOZYME THERAPEUTICS COM Put 23,700 1,532 n/a n/a n/a
2021-08-10 2021-06-30 13F HALOZYME THERAPEUTICS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2021-05-13 2021-03-31 13F HALOZYME THERAPEUTICS COM Put 85,600 5,606.67 3,569 5,476.56 n/a n/a n/a
2021-02-11 2020-12-31 13F HALOZYME THERAPEUTICS COM Put 1,500 -93.21 64 -88.98 n/a n/a n/a
2020-11-12 2020-09-30 13F HALOZYME THERAPEUTICS COM Put 22,100 -2.21 581 -4.13 n/a n/a n/a
2020-08-12 2020-06-30 13F HALOZYME THERAPEUTICS COM Put 22,600 -20.42 606 18.59 n/a n/a n/a
2020-05-12 2020-03-31 13F HALOZYME THERAPEUTICS COM Put 28,400 -39.96 511 -39.09 n/a n/a n/a
2020-02-12 2019-12-31 13F HALOZYME THERAPEUTICS COM Put 47,300 -12.24 839 0.36 n/a n/a n/a
2019-11-08 2019-09-30 13F HALOZYME THERAPEUTICS COM Put 53,900 247.74 836 214.29 n/a n/a n/a
2019-08-12 2019-06-30 13F HALOZYME THERAPEUTICS COM Put 15,500 -47.28 266 -43.76 n/a n/a n/a
2019-05-13 2019-03-31 13F HALOZYME THERAPEUTICS COM Put 29,400 -19.45 473 -11.42 n/a n/a n/a
2019-02-12 2018-12-31 13F HALOZYME THERAPEUTICS COM Put 36,500 19.28 534 -3.96 n/a n/a n/a
2018-11-13 2018-09-30 13F HALOZYME THERAPEUTICS COM Put 30,600 31.33 556 41.48 n/a n/a n/a
2018-08-10 2018-06-30 13F HALOZYME THERAPEUTICS COM Put 23,300 11.48 393 -3.91 n/a n/a n/a
2018-05-11 2018-03-31 13F HALOZYME THERAPEUTICS COM Put 20,900 -58.61 409 -60.02 n/a n/a n/a
2018-02-12 2017-12-31 13F HALOZYME THERAPEUTICS COM Put 50,500 66.12 1,023 93.75 n/a n/a n/a
2017-11-13 2017-09-30 13F HALOZYME THERAPEUTICS COM Put 30,400 46.86 528 99.25 n/a n/a n/a
2017-08-11 2017-06-30 13F HALOZYME THERAPEUTICS COM Put 20,700 39.86 265 38.02 n/a n/a n/a
2017-05-12 2017-03-31 13F HALOZYME THERAPEUTICS COM Put 14,800 35.78 192 77.78 n/a n/a n/a
2017-02-10 2016-12-31 13F HALOZYME THERAPEUTICS COM Put 10,900 5.83 108 -12.90 n/a n/a n/a
2016-11-10 2016-09-30 13F HALOZYME THERAPEUTICS COM Put 10,300 -20.77 124 10.71 n/a n/a n/a
2016-08-12 2016-06-30 13F HALOZYME THERAPEUTICS COM Put 13,000 -12.75 112 -20.57 n/a n/a n/a
2016-05-13 2016-03-31 13F HALOZYME THERAPEUTICS COM Put 14,900 106.94 141 12.80 n/a n/a n/a
2016-02-12 2015-12-31 13F HALOZYME THERAPEUTICS COM Put 7,200 -75.43 125 -68.19 n/a n/a n/a
2015-11-13 2015-09-30 13F HALOZYME THERAPEUTICS COM Put 29,300 208.42 393 82.79 n/a n/a n/a
2015-08-13 2015-06-30 13F HALOZYME THERAPEUTICS COM Put 9,500 215 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.